Publication dates

All regions

Insulin Industry, September 2014 Market Reports from Top Publishers

You might be interested in: medical equipment, drug, therapeutics, more »


 
1-20 of about 400 reports for Insulin

InsuLine Medical Ltd. - Strategic SWOT Analysis Review

InsuLine Medical Ltd. - Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • August 2014
  • by Global Data

... Are incorporated in the profile to assist your academic or business research needs. insuline medical ltd. - Strategic swot analysis review table of contents section 1 - about the company ...

Insuline Medical Ltd

Insuline Medical Ltd

  • $ 55
  • Company report
  • August 2014
  • by Wright Investors' Service

... insuline medical ltd a textual analysis of the financial results for insuline medical ltd compared to selected competitors. Also included are quantitative analyses of the company's financial ...

Insulin Pen Market, Users (Reusable & Prefilled) & Forecast - Worldwide Analysis

Insulin Pen Market, Users (Reusable & Prefilled) & Forecast - Worldwide Analysis

  • $ 1 990
  • Industry report
  • August 2014
  • by Renub Research

... Devices market. Knowing these facts, the major players in the insulin pen devices market are strategically focusing on the asian market, in order to cater the rapidly increasing demand of insulin pen ...

Vildagliptin  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Vildagliptin - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Company report
  • August 2014
  • by Ark Patent Intelligence

... A thiazolidinedione or insulininnovator:novartis (galvus, jalra, icandra, xiliarx, zomarist, eucreas, sobrea, galvumet)country coverage:# australia# canada# france # germany ...

Insulin Aspart  - Comprehensive patent search

Insulin Aspart - Comprehensive patent search

  • $ 10 118
  • Company report
  • August 2014
  • by Ark Patent Intelligence

... Documents and national registers is provided at no additional charge. insulin aspart - comprehensive patent search used by the world's leading pharmaceutical companies and legal teams ...

Insulin Glargine  - Comprehensive patent search

Insulin Glargine - Comprehensive patent search

  • $ 10 118
  • Company report
  • August 2014
  • by Ark Patent Intelligence

... Documents and national registers is provided at no additional charge. insulin glargine - comprehensive patent search used by the world's leading pharmaceutical companies and legal teams ...

Insulin Lispro  - Comprehensive patent search

Insulin Lispro - Comprehensive patent search

  • $ 10 118
  • Company report
  • August 2014
  • by Ark Patent Intelligence

... Documents and national registers is provided at no additional charge. insulin lispro - comprehensive patent search used by the world's leading pharmaceutical companies and legal teams ...

 Insulin Resistance-Pipeline Insights, 2014

Insulin Resistance-Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • August 2014
  • by Delve Insight

... This indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under insulin resistance. This report provides information on the therapeutic development based ...

2014 Deep Research Report on Global and China Diabetes Drugs Industry

2014 Deep Research Report on Global and China Diabetes Drugs Industry

  • $ 2 200
  • Industry report
  • August 2014
  • by QY Research Group

... The gdp growth forecasts for russia changed in 2013 29table china insulin industry policy 41table novo nordisk insulin product specifications (us market) 51table glimepiride tablets ...

Self Administered Injectables to 2020

Self Administered Injectables to 2020

  • $ 3 850
  • Industry report
  • August 2014
  • by Greystone Research Associates

... Inflammatoryanticoagulantsfertilityhematopoieticshepatitis chormone therapy/replacementinsulins/glycemic controlmultiple sclerosisosteoporosisself administered branded drug product analysis & market data ...

About 3 900 reports for Insulin

Download Unlimited Documents from Trusted Public Sources

Global Insulin Markets

  • Opportunities and Challenges for Biosimilars: What's on the Hori...
  • January 2012
    13 pages
  • Insulin  

  • United States  

View report >

13 Companies for Insulin

Read our Company Profiles

Eli Lilly and Co.

United States

Medtronic Inc.

United States

Abbott Laboratories

United States

Lilly and Co.

United States

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.